Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic

Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse
Gerald CochranAdam J Gordon

Abstract

Medications for opioid use disorder (MOUD), such as methadone and buprenorphine, are effective strategies for treatment of opioid use disorder (OUD) and reducing overdose risk. MOUD treatment rates continue to be low across the US, and currently, some evidence suggests access to evidence-based treatment is becoming increasingly difficult for those with OUD as a result of the 2019 novel corona virus (COVID-19). A major underutilized source to address these serious challenges in the US is community pharmacy given the specialized training of pharmacists, high levels of consumer trust, and general availability for accessing these service settings. Canadian, Australian, and European pharmacists have made important contributions to the treatment and care of those with OUD over the past decades. Unfortunately, US pharmacists are not permitted to prescribe MOUD and are only currently allowed to dispense methadone for the treatment of pain, not OUD. US policymakers, regulators, and practitioners must work to facilitate this advancement of community pharmacy-based through research, education, practice, and industry. Advancing community pharmacy-based MOUD for leading clinical management of OUD and dispensation of treatment medications wi...Continue Reading

References

Jun 1, 2005·TheScientificWorldJournal·Salvatore M GiacomuzziAlexander Vigl
Sep 25, 2007·The American Journal of Drug and Alcohol Abuse·Alexander M Ponizovsky, Alexander Grinshpoon
Jun 1, 2010·Substance Use & Misuse·Joseph A KotarbaEloise Dunlap
Mar 26, 2011·American Journal of Pharmaceutical Education·Paul W JungnickelUNKNOWN AACP Special Committee on Substance Abuse and Pharmacy Education
Jul 21, 2011·Current Psychiatry Reports·Elizabeth M OlivaAlex H S Harris
Jan 1, 2011·The Australasian Medical Journal·B B ChaarC Day
Apr 10, 2013·The International Journal on Drug Policy·Hanna UosukainenJuha H O Turunen
Apr 11, 2013·Journal of the American Pharmacists Association : JAPhA·UNKNOWN American Pharmacists Association Foundation and American Pharmacists Association
Sep 10, 2013·International Journal of Clinical Pharmacy·Natasha S KhanCate M Whittlesea
Nov 20, 2013·Psychiatric Services : a Journal of the American Psychiatric Association·Cindy Parks ThomasMiriam E Delphin-Rittmon
Nov 22, 2013·Journal of the American Pharmacists Association : JAPhA
Dec 18, 2013·Journal of Substance Abuse Treatment·Joseph TkaczCharles Ruetsch
Jan 29, 2014·Addiction Science & Clinical Practice·Babak TofighiJoshua D Lee
Mar 13, 2014·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Arthur R WilliamsEllie Grossman
Apr 25, 2014·The New England Journal of Medicine·Nora D VolkowStephen S Cha
Aug 29, 2014·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Bridget McClureHelena Hansen
Jan 15, 2015·Annals of Family Medicine·Roger A RosenblattEric H Larson
Jun 13, 2015·American Journal of Public Health·Christopher M JonesElinore McCance-Katz
Aug 8, 2015·Harm Reduction Journal·Traci C GreenAlexander Y Walley
Aug 21, 2015·Journal of Addiction Medicine·Gerald CochranRalph Tarter
Jan 3, 2016·The International Journal on Drug Policy·Catriona MathesonChristine Bond
Mar 10, 2016·Substance Abuse Treatment, Prevention, and Policy·Benedikt FischerJürgen Rehm
Nov 5, 2016·Drug and Alcohol Dependence·Li-Tzy WuMarvin S Swartz
Dec 17, 2016·Medical Care·Gerald CochranJulie M Donohue
Mar 16, 2017·Journal of the American Pharmacists Association : JAPhA·Kate J MortonKaren Clark
Apr 28, 2017·BMJ : British Medical Journal·Luis SordoRoberto Pastor-Barriuso
Jun 1, 2017·The New England Journal of Medicine·Nora D Volkow, Francis S Collins
Aug 17, 2017·PloS One·Dima Mazen QatoG Caleb Alexander
Jul 1, 2015·Integrated Pharmacy Research & Practice·Albert T Bach, Jeffery A Goad
Mar 30, 2018·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Jessica J WyseTravis I Lovejoy

❮ Previous
Next ❯

Citations

Sep 17, 2020·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Allison M GustavsonHildi J Hagedorn
Aug 18, 2020·Progress in Neuro-psychopharmacology & Biological Psychiatry·Jasmina MalletYann Le Strat
Aug 7, 2021·The International Journal on Drug Policy·Phillip L MarottaLouisa Gilbert
Aug 26, 2021·Substance Use & Misuse·Deepika RaoJohn R Tomko

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association
Taylor BeachlerAlain H Litwin
American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Beth M DeRonneErin E Krebs
© 2021 Meta ULC. All rights reserved